| 1 |
30122995 |
10.2147/CMAR.S157632 |
2022 |
Clinical and biological implications of <i>IDH1/2</i> in acute myeloid leukemia with <i>DNMT3A</i><sup>mut</sup>. |
DNMT3A |
| 2 |
30122998 |
10.2147/CMAR.S166714 |
2022 |
Biological and clinical influences of <i>NPM1</i> in acute myeloid leukemia patients with <i>DNMT3A</i> mutations. |
DNMT3A |
| 3 |
33849798 |
10.1016/j.clml.2021.03.002 |
2022 |
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL. |
DNMT3A |
| 4 |
34078586 |
10.1016/j.clml.2021.04.014 |
2022 |
Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events. |
DNMT3A |
| 5 |
34164626 |
10.1158/2643-3230.BCD-20-0203 |
2022 |
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients. |
DNMT3A |
| 6 |
34230442 |
10.1097/CCO.0000000000000773 |
2022 |
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment. |
DNMT3A |
| 7 |
34376373 |
10.1016/j.clml.2021.07.011 |
2022 |
Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients. |
DNMT3A |
| 8 |
34751409 |
10.3892/or.2021.8221 |
2022 |
KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells. |
DNMT3A |
| 9 |
34840089 |
10.1016/j.clml.2021.10.015 |
2022 |
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations. |
DNMT3A |
| 10 |
34847227 |
10.1182/bloodadvances.2021004926 |
2022 |
Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia. |
DNMT3A |
| 11 |
34926267 |
10.3389/fonc.2021.765544 |
2022 |
<i>SEPT6</i>_<i>TRIM33</i> Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas. |
DNMT3A |
| 12 |
34998786 |
10.1016/j.clml.2021.12.008 |
2022 |
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia. |
DNMT3A |
| 13 |
35027675 |
10.1038/s41409-022-01567-z |
2022 |
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation. |
DNMT3A |
| 14 |
35027991 |
|
2022 |
Update on recurrent mutations in angioimmunoblastic T-cell lymphoma. |
DNMT3A |
| 15 |
35064935 |
10.1111/his.14619 |
2022 |
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. |
DNMT3A |
| 16 |
35247197 |
10.1007/s12094-022-02781-3 |
2022 |
Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia. |
DNMT3A |
| 17 |
35256801 |
10.1038/s41591-022-01708-3 |
2022 |
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. |
DNMT3A |
| 18 |
35280829 |
10.3389/fonc.2022.811151 |
2022 |
Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing. |
DNMT3A |
| 19 |
35301414 |
10.1038/s41379-022-01022-w |
2022 |
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. |
DNMT3A |
| 20 |
35380239 |
10.1007/s00277-022-04806-x |
2022 |
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation. |
DNMT3A |
| 21 |
35385357 |
10.1073/pnas.2120787119 |
2022 |
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases. |
DNMT3A |
| 22 |
35459427 |
10.1080/10428194.2022.2064987 |
2022 |
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated <i>NPM1</i>: a single center study. |
DNMT3A |
| 23 |
35533245 |
10.1158/2643-3230.BCD-21-0177 |
2022 |
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. |
DNMT3A |
| 24 |
35577752 |
10.1016/j.clml.2022.04.015 |
2022 |
Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma. |
DNMT3A |
| 25 |
35593442 |
10.1177/23247096221097523 |
2022 |
DNA Methyl Transferase 3A (DNMT3A) Mutation Presenting as Isolated Pure Red Cell Aplasia. |
DNMT3A |
| 26 |
35639959 |
10.1182/blood.2021015019 |
2022 |
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T-cells in PTCL-NOS. |
DNMT3A |
| 27 |
35652795 |
10.1080/10428194.2022.2081323 |
2022 |
The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing. |
DNMT3A |
| 28 |
35835912 |
10.1038/s41588-022-01121-z |
2022 |
Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. |
DNMT3A |
| 29 |
35846192 |
10.1002/jha2.354 |
2022 |
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone. |
DNMT3A |
| 30 |
35895386 |
10.1111/bjd.21791 |
2022 |
Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. |
DNMT3A |
| 31 |
35995702 |
10.1016/j.clml.2022.07.009 |
2022 |
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma. |
DNMT3A |
| 32 |
36012614 |
10.3390/ijms23169349 |
2022 |
Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma. |
DNMT3A |
| 33 |
36093687 |
10.3233/CBM-220013 |
2022 |
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients. |
DNMT3A |
| 34 |
25289094 |
10.3892/ol.2014.2481 |
2021 |
Knockdown of DNA methyltransferase-1 inhibits proliferation and derepresses tumor suppressor genes in myeloma cells. |
DNMT3A |
| 35 |
30583461 |
10.3390/cancers11010011 |
2021 |
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. |
DNMT3A |
| 36 |
31028364 |
10.1038/s41379-019-0279-8 |
2021 |
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. |
DNMT3A |
| 37 |
31547729 |
10.1080/10428194.2019.1666377 |
2021 |
Methyltransferase DNMT3B in leukemia. |
DNMT3A |
| 38 |
31804006 |
10.1002/cam4.2757 |
2021 |
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. |
DNMT3A |
| 39 |
31842651 |
10.1080/10428194.2019.1702177 |
2021 |
Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromes. |
DNMT3A |
| 40 |
31961069 |
10.1002/ajmg.a.61475 |
2021 |
Tatton-Brown-Rahman syndrome: Six individuals with novel features. |
DNMT3A |
| 41 |
32091281 |
10.1080/10428194.2020.1723016 |
2021 |
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>. |
DNMT3A |
| 42 |
32442302 |
10.1182/bloodadvances.2020001636 |
2021 |
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. |
DNMT3A |
| 43 |
32469082 |
10.1002/cncr.32866 |
2021 |
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. |
DNMT3A |
| 44 |
32945366 |
10.3892/ijmm.2020.4686 |
2021 |
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis. |
DNMT3A |
| 45 |
32947237 |
10.1016/j.tranon.2020.100855 |
2021 |
Identification of clinical molecular targets for childhood Burkitt lymphoma. |
DNMT3A |
| 46 |
32994141 |
10.1016/j.jgg.2020.04.006 |
2021 |
DNA methyltransferases in hematological malignancies. |
DNMT3A |
| 47 |
33043739 |
10.1080/10428194.2020.1832661 |
2021 |
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. |
DNMT3A |
| 48 |
33160401 |
10.1186/s13148-020-00962-x |
2021 |
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma. |
DNMT3A |
| 49 |
33161783 |
10.1080/10428194.2020.1832664 |
2021 |
Identification of two novel mutations in human acute myeloid leukemia cases. |
DNMT3A |
| 50 |
33224395 |
10.14740/jh760 |
2021 |
Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant <i>De Novo</i> Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor. |
DNMT3A |
| 51 |
33436855 |
10.1038/s41598-020-80613-6 |
2021 |
Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia. |
DNMT3A |
| 52 |
33450231 |
10.1016/j.jbc.2021.100285 |
2021 |
Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice. |
DNMT3A |
| 53 |
33457258 |
10.21037/tau-20-1343 |
2021 |
Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review. |
DNMT3A |
| 54 |
33496747 |
10.1182/bloodadvances.2020003081 |
2021 |
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma. |
DNMT3A |
| 55 |
33546774 |
10.1186/s40164-021-00200-x |
2021 |
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas. |
DNMT3A |
| 56 |
33562071 |
10.3390/curroncol28010079 |
2021 |
Novel Mutations in a Lethal Case of Lymphomatous Adult T Cell Lymphoma with Cryptic Myocardial Involvement. |
DNMT3A |
| 57 |
33634864 |
10.1002/ijc.33527 |
2021 |
Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis. |
DNMT3A |
| 58 |
33650043 |
10.1007/s00428-021-03071-z |
2021 |
Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring. |
DNMT3A |
| 59 |
33708776 |
10.3389/fmed.2021.584507 |
2021 |
Case Report: Refusal of an Veno-Arterial Extracorporeal Membrane Oxygenation Due to Malignant Disease? - An Extremely Rare Form of Cardiac Involvement in Acute Myeloid Leukemia. |
DNMT3A |
| 60 |
33711909 |
10.1080/10428194.2021.1894650 |
2021 |
Mutational spectrum of <i>de novo NPM1</i>-mutated acute myeloid leukemia patients older than 75 years. |
DNMT3A |
| 61 |
33739791 |
10.1097/PAS.0000000000001646 |
2021 |
Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. |
DNMT3A |
| 62 |
33876209 |
10.1182/blood.2020010510 |
2021 |
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. |
DNMT3A |
| 63 |
33913388 |
10.1080/10428194.2021.1919661 |
2021 |
Difference in gene mutation profile in patients with refractory/relapsed versus newly diagnosed acute myeloid leukemia based on targeted next-generation sequencing. |
DNMT3A |
| 64 |
33941203 |
10.1186/s13045-021-01068-4 |
2021 |
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL. |
DNMT3A |
| 65 |
33990228 |
10.1186/s40164-021-00224-3 |
2021 |
Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas. |
DNMT3A |
| 66 |
34039737 |
10.1126/scitranslmed.abc4834 |
2021 |
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup. |
DNMT3A |
| 67 |
34065087 |
10.3390/ijms22095013 |
2021 |
The Impact of Epigenetic Modifications in Myeloid Malignancies. |
DNMT3A |
| 68 |
34093648 |
10.3389/fgene.2021.648709 |
2021 |
Exhausting circ_0136474 and Restoring miR-766-3p Attenuate Chondrocyte Oxidative Injury in IL-1β-Induced Osteoarthritis Progression Through Regulating DNMT3A. |
DNMT3A |
| 69 |
34198843 |
10.3390/ijms22116099 |
2021 |
Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy. |
DNMT3A |
| 70 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
DNMT3A |
| 71 |
34615796 |
10.11406/rinketsu.62.1367 |
2021 |
[Epigenetic abnormalities in non-Hodgkin lymphomas]. |
DNMT3A |
| 72 |
26137062 |
10.3892/ol.2015.3038 |
2020 |
Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab. |
DNMT3A |
| 73 |
28487787 |
10.1155/2017/5083463 |
2020 |
EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in <i>ASXL1</i>, <i>BCOR</i>, <i>CDKN2A</i>, <i>NF1</i>, and <i>TP53</i>. |
DNMT3A |
| 74 |
29629950 |
10.1097/PAI.0000000000000644 |
2020 |
A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification. |
DNMT3A |
| 75 |
30655366 |
10.3324/haematol.2018.197848 |
2020 |
<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia. |
DNMT3A |
| 76 |
30715169 |
10.1093/asj/sjy311 |
2020 |
Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). |
DNMT3A |
| 77 |
30829413 |
10.1002/ajh.25450 |
2020 |
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma. |
DNMT3A |
| 78 |
30926392 |
10.1016/j.clml.2019.02.001 |
2020 |
Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients. |
DNMT3A |
| 79 |
30948995 |
10.1080/08998280.2018.1479579 |
2020 |
Early T-cell precursor acute lymphoblastic leukemia with <i>KRAS</i> and <i>DNMT3A</i> mutations and unexpected monosomy 7. |
DNMT3A |
| 80 |
30952970 |
10.1038/s41379-019-0254-4 |
2020 |
The pathological features of angioimmunoblastic T-cell lymphomas with IDH2<sup>R172</sup> mutations. |
DNMT3A |
| 81 |
31060628 |
10.1186/s13148-019-0663-8 |
2020 |
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells. |
DNMT3A |
| 82 |
31145495 |
10.1002/ajh.25517 |
2020 |
The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML. |
DNMT3A |
| 83 |
31184232 |
10.1080/10428194.2019.1627539 |
2020 |
Common clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemia. |
DNMT3A |
| 84 |
31204875 |
10.1080/10428194.2019.1627541 |
2020 |
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in <i>TET2</i>, <i>DNMT3</i> and <i>CUX1</i> - azacitidine induces only lymphoma remission. |
DNMT3A |
| 85 |
31282240 |
10.1080/10428194.2019.1633631 |
2020 |
HIV portends a poor prognosis in myelodysplastic syndromes. |
DNMT3A |
| 86 |
31371502 |
10.1073/pnas.1903059116 |
2020 |
Paradoxical association of TET loss of function with genome-wide DNA hypomethylation. |
DNMT3A |
| 87 |
31392726 |
10.1002/jcp.29085 |
2020 |
Long noncoding RNA MEG3 silencing protects against hypoxia-induced pheochromocytoma-12 cell injury through inhibition of TIMP2 promoter methylation. |
DNMT3A |
| 88 |
31522815 |
10.1016/j.bbrc.2019.09.022 |
2020 |
MiR-33b-3p promotes chondrocyte proliferation and inhibits chondrocyte apoptosis and cartilage ECM degradation by targeting DNMT3A in osteoarthritis. |
DNMT3A |
| 89 |
31594013 |
10.1055/a-0597-7606 |
2020 |
[Current standard in diagnostic and therapy of peripheral T-cell lymphoma]. |
DNMT3A |
| 90 |
31859368 |
10.1002/path.5376 |
2020 |
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell. |
DNMT3A |
| 91 |
31869410 |
10.1182/bloodadvances.2019000925 |
2020 |
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes. |
DNMT3A |
| 92 |
31932841 |
10.1182/blood.2019003330 |
2020 |
Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis. |
DNMT3A |
| 93 |
31965269 |
10.1007/s00277-020-03911-z |
2020 |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax. |
DNMT3A |
| 94 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
DNMT3A |
| 95 |
32271188 |
10.1097/PAS.0000000000001470 |
2020 |
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group. |
DNMT3A |
| 96 |
33363958 |
10.1002/ccr3.3430 |
2020 |
Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review. |
DNMT3A |
| 97 |
27019871 |
10.1016/j.trecan.2015.12.006 |
2019 |
The Impact of DNA Methylation in Hematopoietic Malignancies. |
DNMT3A |
| 98 |
27677595 |
10.1038/srep34222 |
2019 |
Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice. |
DNMT3A |
| 99 |
27690235 |
10.1371/journal.pgen.1006334 |
2019 |
Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma. |
DNMT3A |
| 100 |
27859003 |
10.1111/bjh.14431 |
2019 |
Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. |
DNMT3A |
Datasets
Models
